Empyrean Capital Partners’s Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CHAA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-533,333
Closed -$171K 194
2022
Q1
$171K Hold
533,333
﹤0.01% 171
2021
Q4
$309K Hold
533,333
0.01% 165
2021
Q3
$352K Buy
+533,333
New +$419K 0.01% 168

Other funds holding CHAA.WS

Empyrean Capital Partners's CHAA.WS Position: Q2 2022 in Review

Empyrean Capital Partners sold out of Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CHAA.WS) in Q2 2022, closing a stake of 533,333 shares — an estimated $171K sold.

Empyrean Capital Partners first reported a position in CHAA.WS in Q3 2021 and held it in 3 quarters. The position peaked at $352K in Q3 2021. 40 funds tracked by Wall St. Rank hold CHAA.WS as of Q2 2022.

  • Empyrean Capital Partners reported no remaining Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
  • Empyrean Capital Partners sold 533,333 Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2022, an estimated $171K.
  • Empyrean Capital Partners first reported a position in Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 3 quarters.
  • Empyrean Capital Partners's Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $352K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2022.

Based on Empyrean Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.